AI in Medicine News ใป ๐ Drug discovery and clinical trials
CancerNetwork ยท 11/13 23:09 UTC

Arturo Loaiza-Bonilla, MD, MSEd, FACP, is co-founder of Massive Bio and system-wide chief of hematology and oncology at St. Luke's. He explains how AI is matching patients to clinical trials and where the technology falls short. He also explains why he left academia to build what oncology was missing.